14. Disorders of the Gallbladder & Biliary Tract
(aligned to GMC PARA map — gallbladder is listed, biliary tract folded in for clinical completeness)
Definition
A spectrum of conditions affecting the gallbladder and biliary tract, most caused by gallstones (cholelithiasis) → may lead to pain, infection, obstruction, jaundice, or pancreatitis.
Gallstone types:
Cholesterol (80%, linked to 5Fs).
Pigment (black/brown; haemolysis, infection).
Mixed (commonest in practice).
Risk Factors “5 Fs” classic
Female, Forty, Fat, Fertile, Fair (Caucasian).
↑ Risk in South Asians (higher pigment stone prevalence in UK).
Other: haemolysis (pigment stones), rapid weight loss, diabetes, pregnancy, Crohn’s (ileal disease).
🔬 Pathophysiology of Gallbladder Disorders
Disorder | Pathophysiology |
---|---|
Biliary colic | Gallstone transiently obstructs cystic duct → ↑ pressure → visceral pain. No infection. |
Acute cholecystitis | Persistent cystic duct obstruction → bile stasis → bacterial infection (E. coli, Klebsiella, Enterococcus) → inflammation + oedema. |
Empyema | Untreated acute cholecystitis → pus in lumen → high risk sepsis → surgical emergency. |
Chronic cholecystitis | Recurrent inflammation → fibrosis + shrunken gallbladder → dysmotility → ↑ gallbladder cancer risk. |
Gallstone ileus | Large stone erodes wall → cholecysto-enteric fistula → stone enters bowel → SBO (terminal ileum). |
Gallbladder cancer | Chronic inflammation (stones, porcelain GB) → dysplasia → adenocarcinoma. Poor prognosis. |

Core Gallbladder Conditions
Disorder | Key Features | Exam Traps |
---|---|---|
Biliary colic | RUQ/epigastric pain (episodic, after fatty meals), radiates to scapula, no fever/jaundice. | Pain not truly colicky — constant. Bloods normal. |
Acute cholecystitis | RUQ pain + fever, Murphy’s sign +, raised WCC/CRP. | USS: wall thickening + pericholecystic fluid. |
Empyema of GB | Pus-filled gallbladder, septic patient. | Needs urgent IV abx + drainage. |
Chronic cholecystitis | Recurrent low-grade RUQ pain, fibrosis. | Follows repeated acute attacks. |
Gallstone ileus | Small Bowel Obstruction (SBO) from stone via fistula. Elderly women. | Rigler’s triad on AXR/CT: SBO + pneumobilia + ectopic stone. |
Gallbladder cancer | Rare, linked to chronic stones/porcelain GB. | Poor prognosis, often incidental. |
📄 Jaundice Framework — Pre-hepatic, Hepatic, Post-hepatic
Type | Pathophysiology | Key Features | Typical Causes | Test Clues |
---|---|---|---|---|
Pre-hepatic | ↑ Haemolysis → excess unconjugated bilirubin exceeds liver conjugation capacity | Mild jaundice, no bilirubinuria, dark stools | Haemolysis (AIHA, sickle cell, G6PD, malaria) | ↑ unconjugated bilirubin, normal LFTs, anaemia, ↑ retics |
Hepatic | Hepatocellular injury or impaired conjugation/excretion → mixed hyperbilirubinaemia | Jaundice ± systemic illness, CLD stigmata | Viral hepatitis, ALD, MASLD, cirrhosis, drugs | ↑ ALT/AST > ALP, deranged INR/albumin |
Post-hepatic (obstructive) | Blocked bile ducts → conjugated bilirubin refluxes into blood | Dark urine, pale stools, pruritus, RUQ pain | Gallstones, strictures, cholangiocarcinoma, pancreatic cancer | ↑ conjugated bilirubin; ↑ ALP/GGT > ALT; duct dilatation on US/MRCP |
💡 Exam Hotspot – Gilbert’s Syndrome
Definition: Benign inherited ↓ UDP-glucuronyl transferase → impaired conjugation of bilirubin.
Features: Isolated unconjugated hyperbilirubinaemia; intermittent mild jaundice (triggered by fasting, illness, alcohol, stress).
Tests: Normal LFTs, no haemolysis, only ↑ unconjugated bilirubin.
Exam Trap: Don’t confuse with hepatic pathology — everything else is normal.
Management: Reassure — no treatment required.
- Placement note: Not a GMC PARA core condition, but very common in exam vignettes to test your jaundice framework knowledge.
🧠 Exam triggers:
Dark urine + pale stools + pruritus → obstructive/ post-hepatic
Normal LFTs + unconjugated bilirubin → pre-hepatic/ Guilbert’s (benign)
Stigmata of CLD → hepatic.
- Anaemia + ↑ reticulocytes + jaundice → pre-hepatic haemolysis.
📎 See also: “Liver Failure (including Cirrhosis)” for detailed intra-hepatic causes and management.
⚠️ Core Biliary Tract Conditions
Disorder | Key Features | Exam Traps |
---|---|---|
Choledocholithiasis | Stone in common bile duct (CBD) → RUQ pain, cholestatic LFTs (↑ALP, ↑bilirubin). | USS may miss CBD stones → MRCP better. |
Ascending cholangitis | Infection + obstruction → Charcot’s triad: RUQ pain, fever, jaundice. Reynolds’ pentad if + hypotension & confusion (sepsis). | Always needs IV abx + urgent biliary decompression (ERCP). |
Obstructive jaundice | Painless jaundice (think malignancy: pancreatic/ampullary/CCA) vs painful (stones). | Courvoisier’s law: palpable, non-tender GB unlikely due to stones (think cancer). |
Gallstone pancreatitis | Gallstone impacts ampulla → blocks bile + pancreatic ducts → acute pancreatitis (lipase > amylase). | Do not confuse with biliary colic/cholecystitis. USS first-line, MRCP for CBD stones. Cholecystectomy after recovery to prevent recurrence. |
🔬 Pathophysiology of Biliary Tract Disorders
Disorder | Pathophysiology |
---|---|
Choledocholithiasis | Gallstone migrates from gallbladder → lodges in common bile duct (CBD) → obstruction of bile outflow → conjugated hyperbilirubinaemia, cholestatic LFTs. |
Ascending cholangitis | Obstructed CBD becomes infected (E. coli, Klebsiella, Enterococcus) → ↑ pressure + bacterial proliferation → systemic sepsis. |
Obstructive jaundice (stones/malignancy) | Bile cannot drain → conjugated bilirubin refluxes into blood → dark urine, pale stools, pruritus. Chronic obstruction → secondary biliary cirrhosis. |
Gallstone pancreatitis | Stone at ampulla of Vater blocks both CBD + pancreatic duct → reflux/activation of pancreatic enzymes → acute pancreatitis. |
Choledocholithiasis = obstruction, no infection.
Cholangitis = obstruction + infection (Charcot’s triad ± Reynolds’ pentad).
Obstructive jaundice can be benign (stone, stricture) or malignant (pancreatic/ampullary/CCA).
Gallstone pancreatitis is a biliary complication but often tested under pancreas.
📦 Additional: Autoimmune Cholestatic Disorders (Not PARA Core, but Exam-Linked)
Feature | Primary Biliary Cholangitis (PBC) | Primary Sclerosing Cholangitis (PSC) |
---|---|---|
Who | Middle-aged women (F>M) | Young/middle-aged men (M>F), strong IBD (UC) link |
Pathophysiology | Autoimmune destruction of intra-hepatic bile ducts | Inflammation + fibrosis of intra & extra-hepatic bile ducts (“onion-skin”) |
Clinical | Pruritus, fatigue, jaundice; xanthelasma/xanthomas, osteoporosis | Fatigue, pruritus, jaundice; recurrent cholangitis; progression to cirrhosis |
Antibody | AMA (anti-mitochondrial, 90–95%) | p-ANCA (non-specific) |
LFTs | Cholestatic: ↑ALP, ↑GGT > ↑ALT/AST | Cholestatic: ↑ALP, ↑GGT; may be fluctuating |
Complications | Cirrhosis, portal HTN, ↑ risk hepatocellular carcinoma | Cirrhosis, cholangiocarcinoma (10–15%), colorectal cancer (with UC) |
Diagnosis | AMA + cholestatic LFTs ± liver biopsy | MRCP/ERCP: multifocal strictures + dilatations (“beading”) |
Management | UDCA (ursodeoxycholic acid), symptom relief (cholestyramine for itch), liver transplant if end-stage | ERCP for dominant strictures, manage complications, liver transplant if end-stage |
🧠 Memory hook
PBC = AMA, intra-hepatic, women, xanthelasma
PSC = p-ANCA, beading ducts, men with UC, cholangiocarcinoma risk
Investigations
Step | Investigation | Purpose |
---|---|---|
Serum amylase or lipase (>3× ULN) | Diagnostic – lipase preferred (more sensitive/specific). | |
FBC, CRP, U&E, LFTs, glucose, calcium, ABG | Assess systemic impact, inflammation, severity. | |
USS abdomen (first-line) | Detect gallstones, gallbladder wall thickening, duct dilatation. | |
MRCP | Non-invasive biliary tree assessment – choledocholithiasis, obstruction. | |
ERCP | Diagnostic + therapeutic (stone removal, stenting) – not first-line. | |
CT abdomen (contrast) | If complications suspected (perforation, pancreatitis, ileus, cancer). | |
Glasgow-Imrie score, CRP >150, APACHE II | Predicts severity, guides HDU/ICU |
💊 Management (Stepwise – NICE / BSG)
Condition | First-line | Escalation / Notes |
---|---|---|
Biliary colic | Analgesia (NSAIDs/opioids), lifestyle advice | Elective laparoscopic cholecystectomy if recurrent |
Acute cholecystitis | Admit, IV fluids, analgesia, IV antibiotics (co-amoxiclav) | Laparoscopic cholecystectomy <1 week (ideally within 72 hrs) |
Choledocholithiasis | ERCP stone extraction ± stent | Then laparoscopic cholecystectomy |
Cholangitis | IV antibiotics (pip-taz or ceftriaxone + metronidazole), sepsis 6 | Urgent ERCP for biliary drainage |
Gallbladder empyema | IV antibiotics + drainage | Surgical consult urgent |
Gallbladder cancer | Staging CT, MDT discussion | Surgery ± palliative care |
📋 Follow-Up
Post-cholecystectomy: recovery usually complete; warn about occasional bile salt diarrhoea.
Gallstone pancreatitis: offer cholecystectomy during same admission.
Gallbladder cancer: oncology/hepatobiliary follow-up, often palliative.
PSC/PBC (if overlap suspected): hepatology monitoring.
Key PARA Exam Traps
Murphy’s sign = cholecystitis, not biliary colic.
Charcot’s triad ± Reynold’s pentad = cholangitis (sepsis, urgent ERCP).
ERCP = therapeutic, not just diagnostic.
Asymptomatic stones = no treatment unless porcelain GB, sickle cell, or very high risk.
Courvoisier’s law = malignancy > stones.
USS first-line, MRCP next for ductal stones, ERCP = therapeutic.
Biliary colic = pain only, normal bloods.
Acute cholecystitis = pain + fever + raised WCC/CRP.
Lipase > amylase for diagnosing gallstone pancreatitis.
📅 Last updated in line with NICE NG104 (Gallstone disease) & BSG Guidelines
Published: 2014 • Last updated: 2022 • Reviewed: August 2025
🔒 PASSMAP ensures all content is PARA-aligned, exam-focused, and NICE-compliant.